News FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain by Medscape • 2018/12/03 • 0 Comments Dextenza is the first FDA-approved intracanalicular insert that delivers dexamethasone to treat ocular pain following ophthalmic surgery for up to 30 days with a single insertion. FDA Approvals Full Story →